期刊
CANCER LETTERS
卷 241, 期 1, 页码 135-141出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2005.10.026
关键词
nasopharyngeal carcinoma; CYP2A6; polymorphism; nitrosamine
类别
Nitrosamine has been identified as a carcinogen for nasopharyngeal carcinoma (NPC). Here, we investigated if a nitrosamine metabolizing gene, cytochrome P450 2A6 (CYP2A6) played an important role in NPC development. Relationships between the disease and the CYP2A6 were studied in 74 NPC patients and 137 age-matched healthy controls by using PCR-RFLP assay to distinguish between a wide type allele, *1A, and two mutant alleles, *1B and *4C. Overall, a significant association between CYP2A6 polymorphism and NPC development was observed (P < 0.05). Individual with mutant alleles had an increased risk for NPC when compared to those with *1A/*1A (OR= 2.37, 95% CI = 1.27-4.46). In addition, males who carried mutant alleles of CYP2A6 had a fivefold increased risk for NPC when compared with those who carried *1A/*1A genotype (OR = 5.02, 95% CI= 1.82-14.14). It is thus suggested that CYP2A6 polymorphism may play a crucial role in NPC susceptibility and it may be used as a risk marker for NPC. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据